Quantinuum (QNT) shares surged 11% to $36.68 on Thursday after Morgan Stanley upgraded the stock to Overweight from Equal-Weight — a tier Morgan Stanley reserves for stocks it expects to outperform their industry over the next 12 to 18 months — with analysts at the bank describing the company as their "top quantum play" in the quantum computing sector.

Quantinuum Inc. Class A common stock trades under the ticker QNT. The advance was all the more notable because it came on a soft day for the broader market: the Nasdaq was under pressure and the S&P 500 was slightly lower, making the jump a distinctly company-specific one. Investing.com reported the stock was up 4.5% in pre-open trading.

Morgan Stanley simultaneously lowered its price target to $62 from $78. The cut reflects a slide in the stock since its June trading debut, though the new target still sits well above Thursday's price. Shares had been trading near a 52-week low of $33.02 before the upgrade. The company's June initial public offering was an industry first, but the stock failed to keep its momentum.

Why Morgan Stanley Likes Quantinuum

Analyst Joseph Moore that Quantinuum leads its pure-play peers in both technology and execution. It also carries the lowest valuation multiple against 2030 revenue projections of any name in its peer group — in effect, the cheapest stock per dollar of forecast revenue — and the bank described current levels as a compelling entry point.

The analysts said "the market is least confident in Quantinuum." They added that the gap between their view and the market's is far larger for this stock than for its rivals.

Quantinuum leads in error correction, which is a key step toward building useful quantum systems: today's quantum processors are error-prone, and error correction combines many unreliable physical qubits into logical qubits that can protect information from noise — widely treated as the gateway to machines capable of commercially useful work. The analysts also praised its published technical results, saying they offer a measure of clarity in a field where peers, by their assessment, make inflated claims.

Insiders have been buyers as well, picking up about $24.7 million in stock over the past year, with no reported selling — purchases that company insiders are required to disclose publicly.

With the change, Quantinuum stands as the only Buy-rated quantum stock in Morgan Stanley's coverage, while IonQ, Infleqtion (INFQ) and Xanadu Quantum Technologies are all rated Equal-Weight.

How the Peers Stack Up

IonQ (IONQ), which like Quantinuum builds trapped-ion machines, closed at $34.35 on Thursday. Morgan Stanley cut its price target to $43 from $49, which still implies about 25% upside. The bank said IonQ has the strongest outside validation of its scaling plan but sits behind Quantinuum on technology. IonQ has yet to show it can repeat earlier error-correction results on Superion, its newest machine, though it does hold a slight edge in manufacturing after buying SkyWater Technology, a US-based semiconductor foundry.

Infleqtion, which develops neutral-atom quantum technology, rose 4% to $9.48 on Thursday. The bank has doubts about its road map, though it noted that an on-time launch of the company's next-generation system in 2027 could serve as a catalyst.

Xanadu, a photonic quantum computing company, climbed 5% to $3.34. Morgan Stanley sees a wide range of outcomes for the stock, from $1 to $9, and said the company may need to raise additional funding.

On the technology side, the trapped-ion developer's Helios system produced 48 error-corrected logical qubits when it launched in late 2025. The company's Sol and Apollo systems are set for 2027 and 2029, respectively, with logical qubit counts expected to reach the hundreds.

Chief Executive Rajeeb Hazra told Barron's that the company is now building on an architecture rather than restarting with each generation. Morgan Stanley sees the largest revenue opportunity for Quantinuum in 2030, in a $10 billion market, and projects a $100 billion market by 2040 — forecasts that frame how early the commercial quantum market remains.

With Helios now deployed, Sol is viewed as the next major catalyst, while the main risk flagged by the bank is any delay to Apollo. QNT closed Thursday's session at $36.68, up 11% on the day.

Source: CoinCentral